Tag: Precedence Research
ASX biotech firm Noxopharm’s new mRNA enhancer to make vaccines safer
Australian biotech company Noxopharm Limited unveiled today the development of a new mRNA vaccine enhancer that will make mRNA vaccines safer by reducing inflammation associated with mRNA vaccines.
Report: 3D printers market size to reach USD 88.61b by 2032
The market for 3D printers will be worth approximately USD 88.61 billion by 2032 and will grow at a CAGR of 17.54 per cent between 2023 and 2032, according to a recent report by Precedence Research.
Featured Article
Navigating energy price volatility with predictive intelligence
Energy price volatility has become a structural feature of modern electricity markets rather than a temporary disruption. For energy-intensive manufacturers and large commercial operators, fluctuating wholesale prices are reshaping how energy costs are managed, making reactive approaches increasingly inadequate.
